Brain-Computer Interfaces: A New Frontier in Neuro-Oncology Care
Brain-Computer Interfaces (BCIs) are opening a new frontier in neuro-oncology care, with the potential to significantly improve patients’ lives. These tools create a connection between the brain and external devices by interpreting neural signals. For patients facing the severe effects of brain tumours, BCIs can enhance independence and overall quality of life.
Helping with stronger communication in neuro-oncology
The most useful application of BCI in neuro-oncology is reestablishing communication for patients with major speech or motor problems caused by brain tumours or their treatment. Brain tumours impact the parts of the brain that are used in language production and motor control. The patients may feel alone and unexpressive in their thoughts due to impacts. Translating brain signals that relate to intended speech or movements into recognisable words, text presented on a screen, or access to assistive equipment is possible due to BCI aids in neuro-oncology communication. Social interaction and communication with their family, caregivers, and healthcare providers improve once the patients start participating actively in their own care decisions. This helps to maintain integrity, mental health, and well-being.
BCI for neurorehabilitation and Independence
BCIs are also being explored for neurorehabilitation in brain cancer patients. As a brain tumour affects movement, mental ability, and everyday activities, these are severe neurological complications. Using BCIs in cognitive training exercises can help regain memory, attention, and mental focus. While giving a sense of individuality, this helps speed up the recovery process. The main aim is to help patients become functionally independent so they can fully return to their lives, along with symptom treatment.
Research to real-life
The field of BCI research for neuro-oncology is continuously advancing. Many researchers are performing experiments and trials to examine the possibilities and improvements of modern technologies. Researchers are looking for implantable BCI devices that may help in precise signal detection and stability over time. Artificial intelligence and machine learning can help enhance BCIs even more, making them fast and user-friendly. Recently, Scalp EEG has been developed to assist in the diagnosis of brain tumours like glioblastoma to accurately detect abnormal signals from brain activities.
While cost, accessibility, and complexity of the technology can pose a hurdle, the focus on innovation can help make a future with BCIs as an important part of comprehensive neuro-oncology care. This offers a new possibility for a better quality of life for patients with brain cancer.
